Delivery Order SPE2DB22D2214-SPE2DB24FS4EN
- Not listed
- This is a firm fixed price delivery order for $13,846.57 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for the supply of 4,564,205,429 units of the pharmaceutical product Ondansetron ODT 4 mg tablet in 30-count packages. The delivery order has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA valued up to $999,999,999.00 through...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 4,563,970,460 units of the pharmaceutical Ondansetron ODT 4 mg tablets, with a ceiling value of $39,663.70 and a performance period through March 15, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,377.96, is for the delivery of 4,567,553,701 units of Ondansetron ODT 4 mg tablets. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $5,373.53 award is for the supply of 4,563,943,906 units of Ondansetron ODT 8 mg tablets. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation. The order is for the supply of 4,563,982,184 units of the pharmaceutical product Ondansetron ODT 4 mg tablets, packaged in 30s. The delivery order has a ceiling value of $5,636.04 and an ultimate completion date of March 18, 2024. No set-aside designation was used. AmerisourceBergen Drug Corporation,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565614740 Ondansetron ODT 4 mg tablets. The contract has a total ceiling value of $2,166.87 and an ultimate completion date of August 29, 2024. AmerisourceBergen was awarded this delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for 4,564,286,529 units of Ondansetron ODT 4 mg tablets, a prescription medication. The contract has a ceiling value of $3,530.53 and a completion date of April 16, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The delivery order, with a ceiling value of $3,071.44 and a period of performance through April 4, 2024, is for the supply of 4,564,150,883 units of the pharmaceutical product ondansetron ODT 8 mg tablet. Amerisourcebergen Drug Corp is the prime contractor on this...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The award is for the provision of a pharmaceutical product, specifically Ondansetron ODT 4 mg tablets, to support military treatment programs and facilities. The delivery order has a ceiling value of $17,104.27 and an ultimate completion date of March 29, 2024. AmerisourceBergen Drug Corp holds an indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The order is for 4,564,042,239 units of the medication Ondansetron ODT 8mg tablets, with a ceiling value of $28,272.28 and a performance period through March 22, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB24FS4ENDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The delivery order is for the supply of 4,564,164,377 units of the drug Ondansetron ODT 8 mg tablet, in packs of 30, with a ceiling value of $4,794.77. The order has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order was issued under that IDC. No set-aside designation was used for this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 4/2/24 |